Clinical Trial Update: Safety and Efficacy of Bivalirudin Versus Heparin for Systemic Anticoagulation in Extracorporeal Membrane Oxygenation [Phase 4]

View source ↗

Summary

A Phase 4 trial updating safety and efficacy of bivalirudin versus heparin for systemic anticoagulation in patients undergoing extracorporeal membrane oxygenati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anticoagulant-associated Complications
• Extracorporeal Membrane Oxygenation Complication

Drugs mentioned

• Bivalirudin (bivalirudin)
• Heparin (unfractionated heparin)

Snippet

Sponsor: Legacy Health System | Conditions: Extracorporeal Membrane Oxygenation Complication, Anticoagulants | Phase 4 | Status: UNKNOWN